NeuroVision Imaging is a developer of digital imaging and diagnostic solutions for Alzheimer's disease.
NeuroVision Imaging's investors include Johnson & Johnson Innovation, Omega Funds, Wildcat Capital Management, Alzheimer's Drug Discovery Foundation, VSP Global.
NeuroVision Imaging is headquartered in Sacramento, United States.
NeuroVision Imaging is a developer of digital imaging and diagnostic solutions for Alzheimer's disease.
NeuroVision Imaging is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NeuroVision Imaging — Funding & Investors." VCBacked, August 24, 2021, https://www.vcbacked.co/company/neurovision-imaging. Accessed September 30, 2026.
VCBacked. (2021). NeuroVision Imaging — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/neurovision-imaging
{{cite web |title=NeuroVision Imaging — Funding & Investors |url=https://www.vcbacked.co/company/neurovision-imaging |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated